Published in Med Monatsschr Pharm on December 01, 2014
The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest (2004) 2.52
A new electrophysiological tool to investigate the spatial neuronal projections within the myenteric ascending reflex of the mouse colon. Clin Exp Pharmacol Physiol (2008) 1.39
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med (Berl) (2005) 1.25
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol (2007) 1.21
Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. J Proteome Res (2010) 1.10
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis (2010) 1.07
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One (2012) 1.06
The pathophysiology of chronic constipation. Can J Gastroenterol (2011) 1.02
Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol (2011) 1.01
Release of anandamide from blood cells. Clin Chem Lab Med (2006) 1.01
Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon. Am J Physiol Gastrointest Liver Physiol (2008) 0.97
Structural differences in the enteric neural network in murine colon: impact on electrophysiology. Am J Physiol Gastrointest Liver Physiol (2003) 0.95
Non-specific abdominal pain and air pollution: a novel association. PLoS One (2012) 0.92
STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr (2012) 0.91
A potential role for GPR55 in gastrointestinal functions. Curr Opin Pharmacol (2012) 0.90
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS). Exp Brain Res (2014) 0.89
Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology (2012) 0.89
Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction. Drug News Perspect (2009) 0.89
Are gap junctions truly involved in inhibitory neuromuscular interaction in mouse proximal colon? Clin Exp Pharmacol Physiol (2006) 0.89
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. Pancreas (2013) 0.89
Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications. Am J Chin Med (2014) 0.89
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology (2013) 0.86
Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40. Angew Chem Int Ed Engl (2013) 0.85
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol (2011) 0.85
Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol (2012) 0.83
Percutaneous endoscopically assisted transenteric full-thickness gastric biopsy: initial experience in humans. Gastrointest Endosc (2011) 0.83
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis. Lab Invest (2013) 0.83
Synthesis and biological evaluation of novel peripherally active morphiceptin analogs. Peptides (2010) 0.82
Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases. Curr Drug Targets (2013) 0.81
Bladder function in a cannabinoid receptor type 1 knockout mouse. BJU Int (2014) 0.81
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.81
Cannabis finds its way into treatment of Crohn's disease. Pharmacology (2013) 0.81
Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. Expert Rev Clin Pharmacol (2010) 0.81
The Chinese herbal preparation Qing Yi Tang (QYT) improves intestinal myoelectrical activity and increases intestinal transit during acute pancreatitis in rodents. Phytother Res (2007) 0.80
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases. J Pharmacol Exp Ther (2013) 0.80
Evaluation of endoscopist and pathologist factors affecting the incidence of microscopic colitis. Can J Gastroenterol (2012) 0.79
A novel method of full-thickness gastric biopsy via a percutaneous, endoscopically assisted, transenteric approach. Gastrointest Endosc (2010) 0.78
The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileus. PLoS One (2013) 0.78
Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis. BMC Gastroenterol (2012) 0.77
ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats. Gastroenterology (2007) 0.77
Effect of tachykinins on ascending and descending reflex pathway in rat small intestine. Acta Pharmacol Sin (2002) 0.77
[Not Available]. Med Monatsschr Pharm (2014) 0.75
Is irritable bowel syndrome a rhinitis of the gut? Gastroenterology (2011) 0.75
Evaluation of lower functional gut disorders. Can J Gastroenterol (2008) 0.75
Lichen planus is an uncommon cause of nonspecific proximal esophageal inflammation. Gut Liver (2013) 0.75
[In Process Citation]. MMW Fortschr Med (2015) 0.75
Chronic constipation: current management and challenges. Can J Gastroenterol (2011) 0.75
Balloon dilation in patients with diffuse esophageal spasm. Gastrointest Endosc (2005) 0.75
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology (2015) 0.75
[Not Available]. Med Monatsschr Pharm (2013) 0.75
Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans. Bioorg Med Chem (2010) 0.75
[Fecal microbiome transfer helps in clostridium infections]. MMW Fortschr Med (2014) 0.75
Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases. Inflamm Bowel Dis (2015) 0.75
Synthesis and opioid activity of novel 6-ketolevorphanol derivatives. Med Chem (2013) 0.75
[In Process Citation]. Med Monatsschr Pharm (2015) 0.75
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection. Dtsch Arztebl Int (2016) 0.75
[Macrogol improved constipation, but not the quality of life]. Med Monatsschr Pharm (2014) 0.75
[In Process Citation]. Med Monatsschr Pharm (2016) 0.75
[Stool transplantation: also an option for irritable bowel syndrome?]. MMW Fortschr Med (2014) 0.75
Enterothorax mimicking pleural effusion. Indian J Gastroenterol (2006) 0.75
Review: The Role of MOP and DOP Receptors in Treatment of Diarrheapredominant Irritable Bowel Syndrome. Mini Rev Med Chem (2016) 0.75
Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2. Basic Clin Pharmacol Toxicol (2009) 0.75
A case of Conn's syndrome revealed after oral sodium phosphate (Fleet) preparation for colonoscopy. J Dig Dis (2010) 0.75